74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Globus Medical Inc (Class A)
Closed
SectorHealthcare
72.04 -4.66
Overview
Share price change
24h
Min
71.54
Max
75.22
Income | -25M 27M |
|---|---|
Sales | 32M 657M |
P/E Sector Avg | 97.6 63.778 |
EPS | 0.84 |
Profit margin | 4.032 |
Employees | 5,300 |
EBITDA | 29M 145M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +30.79% upside |
Next Earnings | 6 May 2025 |
|---|
Market Cap | -2.7B 10B |
|---|---|
Previous open | 76.7 |
Previous close | 72.04 |
News Sentiment
By Acuity
65%
35%
344 / 386 Healthcare
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
Globus Medical Inc (Class A) Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Globus Medical Inc (Class A) Forecast
Price Target
By TipRanks
30.79% upside
12 Months Forecast
Average 98.75 USD 30.79%
High 115 USD
Low 82 USD
Based on 14 Wall Street analysts offering 12 month price targets forGlobus Medical Inc (Class A) - Dist in the last 3 months.
Sentiment
By Acuity
344 / 386 Healthcare
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Globus Medical Inc (Class A)
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
